Fred T. Bizzarro

Allosteric Activators of Glucokinase: Potential Role in Diabetes Therapy

Joseph Grimsby, Ramakanth Sarabu, Wendy L. Corbett et al. · Science · 2003 · 537 citations

Medicine, Biochemistry, Endocrinology +17

Discovery of Piragliatin—First Glucokinase Activator Studied in Type 2 Diabetic Patients

Ramakanth Sarabu, Fred T. Bizzarro, Wendy L. Corbett et al. · Journal of Medicinal Chemistry · 2012 · 98 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Syntheses of (2<i>R</i>, 4′<i>R</i>, 8′<i>R</i>)‐α‐Tocopherol and (2<i>R</i>, 3′<i>E</i>, 7′<i>E</i>)‐α‐Tocotrienol

John W. Scott, Fred T. Bizzarro, David R. Parrish et al. · Helvetica Chimica Acta · 1976 · 81 citations

Pharmacy, Biochemistry, Green Chemistry +5

Discovery, Structure−Activity Relationships, Pharmacokinetics, and Efficacy of Glucokinase Activator (2<i>R</i>)-3-Cyclopentyl-2-(4-methanesulfonylphenyl)-<i>N</i>-thiazol-2-yl-propionamide (RO0281675)

Nancy-Ellen Haynes, Wendy L. Corbett, Fred T. Bizzarro et al. · Journal of Medicinal Chemistry · 2010 · 46 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Syntheses and biological evaluation of vinblastine congeners

Martin E. Kuehne, William G. Bornmann, István E. Markó et al. · Organic & Biomolecular Chemistry · 2003 · 41 citations

Medicine, Medicinal Chemistry, Pharmacology +8